Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure (Q43961153)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article published in April 2002
Language Label Description Also known as
English
Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure
scientific article published in April 2002

    Statements

    title
    Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    11956122
    retrieved
    28 November 2017
    author name string
    Michael R Bristow
    series ordinal
    2
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    11956122
    retrieved
    28 November 2017
    Theressa J Wright
    series ordinal
    7
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    11956122
    retrieved
    28 November 2017
    Moxonidine Safety and Efficacy (MOXSE) Investigators
    series ordinal
    8
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    11956122
    retrieved
    28 November 2017

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q43961153&oldid=2105040283"